Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $6.96 Million - $9.82 Million
-118,200 Reduced 51.39%
111,800 $8.98 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $10.5 Million - $14 Million
205,000 Added 820.0%
230,000 $14.3 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $1.39 Million - $1.95 Million
25,000 New
25,000 $1.55 Million
Q4 2022

Feb 14, 2023

SELL
$48.76 - $77.67 $4.14 Million - $6.6 Million
-85,000 Reduced 68.0%
40,000 $2.04 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $7.68 Million - $10.8 Million
125,000 New
125,000 $8.79 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.